Growth GuidanceThe company issued FY25 guidance at $42-$44M, demonstrating a growth rate in line with last year's, positioning SI in a strong position to capture market share.
IPO Proceeds UtilizationThe anticipated use of IPO proceeds for sales force and commercial organization expansion is a key growth driver for Shoulder Innovations.
Technological EdgeProVoyance, an industry-leading, AI-enabled pre-op planning tool, provides a competitive edge as enabling technology becomes more pertinent for the shoulder arthroplasty space.